Dublin Core
Title
The Effectiveness of Pisbro in Increasing Hemoglobin Levels in Pregnant Women as an Effort to Prevent Stunting at the Sentosa Baru Community Health Center in 2025
Subject
Pregnant Women; Anemia; Hemoglobin; Ambon Banana; Broccoli
Description
Background: nemia has a substantial impact on national economic development because it is associated with impaired cognitive and motor function in children and diminished productivity in adults. Among pregnant women, iron deficiency anemia can cause growth
and developmental disorders and is strongly linked to adverse pregnancy outcomes such as low birth weight (LBW) and preterm delivery. If left untreated, anemia may worsen theihealth and quality of life of millions of women and hinder children’s growth, development, and educational achievement. The presence of anemia itself reflects underlying malnutrition and poor health status. Worldwide, anemia affected 32 million pregnant women (37%) and 539 million non-pregnant women (30%) between the ages of 15 and 49 in 2019. Methods: The research method used is quantitative with a Quasi-Experimental design using the Two This study employed a quantitative approach with a quasi-experimental design,specifically the Two-Group Pretest–Posttest method, which involved imeasuring hemoglobin levels before and after treatment in both intervention and control groups. A total of 40 pregnant women participated, with 20 assigned to the control group (not receiving Pisbro cookies) and 20 to the intervention group (receiving Pisbro cookies). Prior to conducting the bivariate analysis, data normality was tested using the Shapiro–Wilk test, which showed that the data were normally distributed (p > 0.05). Subsequently, an independent t-test was
performed, and the results indicated significant differences between the groups (p < 0.05) at a confidence level of α = 0.05. Data analysis was carried out using SPSS version 22.Results:The independent t-test analysis revealed that the mean hemoglobin concentration in the
intervention group (given Pisbro cookies) was 9.795 ± 0.5145, while the control group (not given Pisbro cookies) had a mean of 9.795 ± 0.5005. Statistical testing produced a p-value of 0.019 (p < 0.05), indicating a significant difference between the two groups. Conclusion: Enhancing hemoglobin levels among pregnant women is essential for preventing adverse maternal and neonatal outcomes, supporting healthy fetal development, and improving maternal well-being.
and developmental disorders and is strongly linked to adverse pregnancy outcomes such as low birth weight (LBW) and preterm delivery. If left untreated, anemia may worsen theihealth and quality of life of millions of women and hinder children’s growth, development, and educational achievement. The presence of anemia itself reflects underlying malnutrition and poor health status. Worldwide, anemia affected 32 million pregnant women (37%) and 539 million non-pregnant women (30%) between the ages of 15 and 49 in 2019. Methods: The research method used is quantitative with a Quasi-Experimental design using the Two This study employed a quantitative approach with a quasi-experimental design,specifically the Two-Group Pretest–Posttest method, which involved imeasuring hemoglobin levels before and after treatment in both intervention and control groups. A total of 40 pregnant women participated, with 20 assigned to the control group (not receiving Pisbro cookies) and 20 to the intervention group (receiving Pisbro cookies). Prior to conducting the bivariate analysis, data normality was tested using the Shapiro–Wilk test, which showed that the data were normally distributed (p > 0.05). Subsequently, an independent t-test was
performed, and the results indicated significant differences between the groups (p < 0.05) at a confidence level of α = 0.05. Data analysis was carried out using SPSS version 22.Results:The independent t-test analysis revealed that the mean hemoglobin concentration in the
intervention group (given Pisbro cookies) was 9.795 ± 0.5145, while the control group (not given Pisbro cookies) had a mean of 9.795 ± 0.5005. Statistical testing produced a p-value of 0.019 (p < 0.05), indicating a significant difference between the two groups. Conclusion: Enhancing hemoglobin levels among pregnant women is essential for preventing adverse maternal and neonatal outcomes, supporting healthy fetal development, and improving maternal well-being.
Creator
Damayanty S
Date
2025
Language
Indonesia